use of azd2171 or a pharmaceutically acceptable salt thereof excluding an azd2171 maleate salt and a taxane, pharmaceutical composition, kit, and method for producing antiangiogenic effect and / or reducing vascular permeability in a warm-blooded animal such as as a human being

摘要

USE OF ZD2171 OR A PHARMACEUTICALLY ACCEPTABLE SALT EXCLUDING AN AZD2171 MALEATE SALT AND A TAXAN, PHARMACEUTICAL COMPOSITION, KIT, AND, METHOD FOR THE PRODUCTION OF AN ANTIANGIOGEN EFFECT OF REABILITY AND / OR ANIMAL SINGLE PURPOSE AS A HUMAN The present invention relates to a method for producing an antiangiogenic effect and / or reducing vascular permeability in a warm-blooded animal such as a human being optionally treated with ionizing radiation, particularly a method. for the treatment of a cancer involving a solid tumor comprising administering AZD2171 in combination with a taxane; a pharmaceutical composition comprising AZD2171 and a taxane; a combination product comprising AZD2171 and a taxane for use in a method of treating a human or animal body by therapy; a kit comprising AZD2171 and a taxane; the use of AZD2171 and a taxane in the manufacture of medicament for use in producing an antiangiogenic effect and / or reducing vascular permeability in a warm-blooded animal such as a human being optionally treated with ionizing radiation.